Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Skyepharma CFO gets cash injection from Vectura merger

Mon, 20th Jun 2016 13:41

(ShareCast News) - Skyepharma's chief financial officer Andrew Derodra has pocketed a healthy cash injection after the completion of the merger with Vectura.Derodra exercised nil-cost options over 150,000 Skyepharma shares that were a bonus in his long-term incentive plan that vested on completion of the merger on Friday and so were automatically converted into new Vectura shares.Under the merger agreement, shares in Skyepharma are exchanged for ordinary shares of 0.025 pence in Vectura at a ratio of 2.7977405 Vectura shares for each Skyepharma share.Derodra, who is remaining part of the management team of the enlarged group, later on Friday sold all 419,661 of his new Vectura shares in London at an average price of £1.536209 per share, making over £644,000.The combined group will see Derodra led by James Ward-Lilley, Vectura's chief executive officer, in the CEO seat, with Vectura's Trevor Phillips as chief operating officer and Vectura chairman Bruno Angelici also chairman of the enlarged group. Top Director BuysGlobalworth Real Estate Investments Limited (GWI)Director name: Papalekas,Ioannis Amount purchased: 10,000 @ € 5.15Value: € 51,500.00Hikma Pharmaceuticals (HIK)Director name: Darwazah,MazenAmount purchased: 70,000 @ 21.65pValue: £15,155.00Hikma Pharmaceuticals (HIK)Director name: Darwazah,SaidAmount purchased: 70,000 @ 21.65pValue: £15,155.00Hikma Pharmaceuticals (HIK)Director name: Al-Husry,AliAmount purchased: 70,000 @ 21.65pValue: £15,155.00Stilo International (STL)Director name: Ashman,DavidAmount purchased: 200,000 @ 5.63pValue: £11,250.00U And I Group (UAI)Director name: Weiner,MatthewAmount purchased: 20,985 @ 1.85pValue: £388.22Johnson Matthey (JMAT)Director name: MacLeod,RobertAmount purchased: 12 @ 2,889.00pValue: £346.68Johnson Matthey (JMAT)Director name: Walker,JohnAmount purchased: 12 @ 2,889.00pValue: £346.68Top Director SellsVectura Group (VEC)Director name: Derodra,AndrewOption sale: 419,661 @ 153.62pValue: £644,687.00Young & Co's Brewery 'a' Shares (YNGA)Director name: Whitehead,PeterAmount purchased: 20,391 @ 1,201.00pValue: £244,895.91Young & Co's Brewery 'a' Shares (YNGA)Director name: Goodyear,StephenAmount purchased: 15,000 @ 1,201.00pValue: £180,150.00Young & Co's Brewery 'a' Shares (YNGA)Director name: Sligo-Young,TorquilAmount purchased: 8,000 @ 1,201.00pValue: £96,080.00Young & Co's Brewery 'a' Shares (YNGA)Director name: Sligo-Young,TorquilAmount purchased: 2,500 @ 1,201.00pValue: £30,025.00
More News
10 Jun 2016 11:06

LONDON MARKET MIDDAY: Risk-Off Mood Hits Stocks As Bond Yields Shrink

Read more
10 Jun 2016 09:50

WINNERS & LOSERS SUMMARY: Vectura Shares Rise After Skyepharma Tie Up

Read more
10 Jun 2016 07:41

Allergy Therapeutics Appoints Skyepharma's Wykeman As Finance Director

Read more
10 Jun 2016 06:56

Vectura-Skyepharma Merger Completed As Scheme Becomes Effective (ALLISS)

Read more
3 Jun 2016 06:17

Vectura Says VR942 Asthma Treatment Phase-One Trials Meet Objective

Read more
26 May 2016 09:47

Vectura reports strong rise in full-year earnings

(ShareCast News) - Vectura´s full-year results edged past forecasts with analysts noting the sharp improvement in its free-cash-flow generation even as they pointed out several potential share price drivers which were looming increasingly closer on the horizon. The manufacturer of airways diseases t

Read more
26 May 2016 06:56

Vectura Sees Narrowed Loss Ahead Of Skyepharma Deal Completion

Read more
24 May 2016 09:30

Vectura teams up with Propeller on inhaler plan

(ShareCast News) - Vectura Group said it was joining forces with Propeller Health to develop inhalers that combine their two technologies. In a statement, Vectura said the plan was to use its dry powder inhaler technology with Propeller's FDA-cleared digital health platform to treat respiratory dise

Read more
24 May 2016 06:49

Vectura Teams Up With Propeller Health To Combine Technology

Read more
20 May 2016 06:29

Vectura Says Skyepharma Deal To Complete By June 10

Read more
19 May 2016 15:06

Earnings, Trading Statements Calendar - Week Ahead

Read more
18 May 2016 07:24

Skyepharma Says Trading Good, Anticipates Full-Year Revenue Growth

Read more
16 May 2016 16:13

Vectura, Skyepharma Merger Cleared By UK Competition Authority

Read more
3 May 2016 14:21

Drug trials using Vectura's Fox nebuliser make progress

(ShareCast News) - A respiratory treatment being developed using Vectura's Fox nebuliser technology device has passed safety and efficacy trials and looks likely to be moved into a Phase II efficacy study in infants. Drug developer Ablynx has published positive results from first-in-infant Phase I/I

Read more
28 Apr 2016 15:00

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.